Vestal Point Capital »

Nektar Therapeutics shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $21M 285k 71.95

More positions owned by Vestal Point Capital

Revolution Medicines (RVMD)
BioMarin Pharmaceutical (BMRN)
Abivax SA Sponsored Ads (ABVX)
Neurocrine Biosciences (NBIX)
Arrowhead Pharmaceuticals (ARWR)
Enliven Therapeutics (ELVN)
Repligen Corporation (RGEN)
Bicara Therapeutics (BCAX)
Nurix Therapeutics (NRIX)
Apogee Therapeutics (APGE)
Ascendis Pharma A/S Sponsored Adr (ASND)
Immunocore Holdings Ads (IMCR)
Taysha Gene Therapies Com Shs (TSHA)
Dyne Therapeutics (DYN)
Sanofi SA Sponsored Adr (SNY)

View all positions for Vestal Point Capital

Top funds holding Nektar Therapeutics

BVF
Two Seas Capital
Vanguard Capital Management
Susquehanna International
Vanguard Group
Two Sigma Investments
BlackRock
Citadel Advisors
Morgan Stanley
Armistice Capital
Invesco
Prosight Management
Sofinnova Ventures
Woodline Partners
Lord, Abbett & Co

View all funds holding Nektar Therapeutics